Treffer 1 - 7 von 7 für Suche 'Monchamp, Travis', Suchdauer: 0,64s Treffer weiter einschränken
  1. 1
    β-Cell Replication Is the Primary Mechanism Subserving the Postnatal Expansion of β-Cell Mass in Humans

    β-Cell Replication Is the Primary Mechanism Subserving the Postnatal Expansion of β-Cell Mass in Humans von MEIER, Juris J, BUTLER, Alexandra E, SAISHO, Yoshifumi, MONCHAMP, Travis, GALASSO, Ryan, BHUSHAN, Anil, RIZZA, Robert A, BUTLER, Peter C

    Veröffentlicht in Diabetes (New York, N.Y.)

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    Efficacy and Safety of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People with Diabetes Treated for 26 Weeks with Multiple Daily Injections in Combination with Insulin Glargine: A Randomized Open-Label Trial (GEMELLI 1)

    Efficacy and Safety of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People with Diabetes Treated for 26 Weeks with Multiple Daily Injections in Combinati... von Garg, Satish K, Wernicke-Panten, Karin, Wardecki, Marek, Kramer, Daniel, Delalande, Francois, Franek, Edward, Sadeharju, Karita, Monchamp, Travis, Mukherjee, Bhaswati, Shah, Viral N


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    129-LB: Similar Efficacy, Safety, and Immunogenicity in People with Diabetes Using SAR341402 or Insulin Aspart: Gemelli 1 Study

    129-LB: Similar Efficacy, Safety, and Immunogenicity in People with Diabetes Using SAR341402 or Insulin Aspart: Gemelli 1 Study von GARG, SATISH K., WERNICKE-PANTEN, KARIN, WARDECKI, MAREK, KRAMER, DANIEL, DELALANDE, FRANCOIS, SHAH, VIRAL N., FRANEK, EDWARD, SADEHARJU, KARITA, MONCHAMP, TRAVIS

    Veröffentlicht in Diabetes (New York, N.Y.)

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  4. 4
    Safety, Immunogenicity, and Glycemic Control of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People with Diabetes Also Using Insulin Glargine: 12-Month Results from the GEMELLI 1 Trial

    Safety, Immunogenicity, and Glycemic Control of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People with Diabetes Also Using Insulin Glargine: 12-Month R... von Garg, Satish K, Wernicke-Panten, Karin, Wardecki, Marek, Kramer, Daniel, Delalande, Francois, Franek, Edward, Sadeharju, Karita, Monchamp, Travis, Miossec, Patrick, Mukherjee, Bhaswati, Shah, Viral N


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  5. 5
    [beta]-cell replication is the primary mechanism subserving the postnatal expansion of [beta]-cell mass in humans.(ORIGINAL ARTICLES)

    [beta]-cell replication is the primary mechanism subserving the postnatal expansion of [beta]-cell mass in humans.(ORIGINAL ARTICLES) von Meier, Juris J, Butler, Alexandra E, Saisho, Yoshifumi, Monchamp, Travis, Galasso, Ryan, Bhushan, Anil, Rizza, Robert A, Butler, Peter C

    Veröffentlicht in Diabetes (New York, N.Y.)

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  6. 6
    Metastatic Inflammatory Myofibroblastic Tumor Imaged by PET/CT

    Metastatic Inflammatory Myofibroblastic Tumor Imaged by PET/CT von Kuo, Phillip H, Spooner, Stacy, Deol, Parminder, Monchamp, Travis

    Veröffentlicht in Clinical nuclear medicine

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  7. 7
    The role of 2-deoxy-2-[ 18F]fluoro-D-glucose positron emission tomography/computed tomography in monitoring the immunosuppressive therapy response of inflammatory myofibroblastic tumor

    The role of 2-deoxy-2-[ 18F]fluoro-D-glucose positron emission tomography/computed tomography in monitoring the immunosuppressive therapy response of inflammatory myofibroblastic t... von Obrzut, Sebastian L., Halpern, Benjamin S., Monchamp, Travis, Grabski, Karsten, Watts, William J., Czernin, Johannes

    Veröffentlicht in Molecular imaging and biology

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: